• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性酪氨酸血症的产前诊断:羊水琥珀酰丙酮的测定

Prenatal diagnosis of hereditary tyrosinaemia: measurement of succinylacetone in amniotic fluid.

作者信息

Gagné R, Lescault A, Grenier A, Laberge C, Mélançon S B, Dallaire L

出版信息

Prenat Diagn. 1982 Jul;2(3):185-8. doi: 10.1002/pd.1970020307.

DOI:10.1002/pd.1970020307
PMID:7145846
Abstract

A method is proposed for prenatal diagnosis in pregnancies at risk of hereditary tryosinaemia. Affected fetuses were detected on the basis of the abnormal presence in the amniotic fluid of succinylacetone, a metabolite previously identified in sera and urines of patients suffering from hereditary tyrosinaemia. Our data show that the forty amniotic control samples had no detectable succinylacetone, while succinylacetone was found in three out of the thirteen cases at risk. Following the parents' decision, these three fetuses were aborted. The ten other mothers who brought their pregnancies to term had normal infants. Enzymatic analysis from two of their aborted fetuses' livers revealed an absence or a low activity of fumarylaceto-acetate hydrolase (EC 3.7.1.2) compared with control fetal livers of the same age.

摘要

本文提出了一种针对有遗传性酪氨酸血症风险的妊娠进行产前诊断的方法。通过检测羊水样本中琥珀酰丙酮的异常存在来发现受影响的胎儿,琥珀酰丙酮是先前在遗传性酪氨酸血症患者的血清和尿液中鉴定出的一种代谢物。我们的数据显示,四十份羊水对照样本中未检测到琥珀酰丙酮,而在十三例有风险的病例中,有三例检测到了琥珀酰丙酮。根据父母的决定,这三名胎儿被终止妊娠。另外十名足月分娩的母亲所生婴儿正常。对其中两名流产胎儿的肝脏进行酶分析发现,与同龄对照胎儿肝脏相比,富马酰乙酰乙酸水解酶(EC 3.7.1.2)缺乏或活性较低。

相似文献

1
Prenatal diagnosis of hereditary tyrosinaemia: measurement of succinylacetone in amniotic fluid.遗传性酪氨酸血症的产前诊断:羊水琥珀酰丙酮的测定
Prenat Diagn. 1982 Jul;2(3):185-8. doi: 10.1002/pd.1970020307.
2
The antenatal diagnosis and aid to the management of hereditary tyrosinaemia by use of a specific and sensitive GC-MS assay for succinylacetone.
J Inherit Metab Dis. 1984;7 Suppl 2:135-6. doi: 10.1007/978-94-009-5612-4_42.
3
First-trimester prenatal diagnosis of tyrosinemia type I by amniotic fluid succinylacetone determination.通过羊水琥珀酰丙酮测定进行孕早期Ⅰ型酪氨酸血症的产前诊断。
Prenat Diagn. 1990 Feb;10(2):133-4. doi: 10.1002/pd.1970100210.
4
Chemical analysis of succinylacetone and 4-hydroxyphenyllactate in amniotic fluid using selective ion monitoring.
Prenat Diagn. 1984 May-Jun;4(3):187-94. doi: 10.1002/pd.1970040305.
5
Genotyping of a case of tyrosinaemia type I with normal level of succinylacetone in amniotic fluid.一例羊水琥珀酰丙酮水平正常的I型酪氨酸血症的基因分型
Prenat Diagn. 1999 Jan;19(1):61-3. doi: 10.1002/(sici)1097-0223(199901)19:1<61::aid-pd455>3.0.co;2-#.
6
A case of tyrosinaemia type I with normal level of succinylacetone in the amniotic fluid.
Prenat Diagn. 1996 Mar;16(3):239-42. doi: 10.1002/(SICI)1097-0223(199603)16:3<239::AID-PD829>3.0.CO;2-W.
7
Neonatal and prenatal diagnosis of hereditary tyrosinaemia.遗传性酪氨酸血症的新生儿及产前诊断
Lancet. 1983 Jun 4;1(8336):1279. doi: 10.1016/s0140-6736(83)92731-9.
8
Stable isotope dilution analysis of succinylacetone using electron capture negative ion mass fragmentography: an accurate approach to the pre- and neonatal diagnosis of hereditary tyrosinemia type I.
Clin Chim Acta. 1988 Feb 15;171(2-3):223-31. doi: 10.1016/0009-8981(88)90147-7.
9
Early prenatal diagnosis of hereditary tyrosinaemia.遗传性酪氨酸血症的早期产前诊断
Lancet. 1985 May 4;1(8436):1038. doi: 10.1016/s0140-6736(85)91633-2.
10
Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia.琥珀酰丙酮的检测及其在遗传性酪氨酸血症大规模筛查中的测量应用。
Clin Chim Acta. 1982 Aug 4;123(1-2):93-9. doi: 10.1016/0009-8981(82)90117-6.

引用本文的文献

1
Development of Flow Injection Analysis Method for the Second-Tier Estimation of Succinylacetone in Dried Blood Spot of Newborn Screening.新生儿筛查干血斑中琥珀酰丙酮二级估算的流动注射分析法的开发
Indian J Clin Biochem. 2022 Jan;37(1):40-50. doi: 10.1007/s12291-020-00944-z. Epub 2021 Jan 6.
2
The Importance of Succinylacetone: Tyrosinemia Type I Presenting with Hyperinsulinism and Multiorgan Failure Following Normal Newborn Screening.琥珀酰丙酮的重要性:新生儿筛查正常后出现高胰岛素血症和多器官功能衰竭的I型酪氨酸血症
Int J Neonatal Screen. 2020 Jun;6(2). doi: 10.3390/ijns6020039. Epub 2020 May 16.
3
Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease.
富马酰乙酰乙酸水解酶缺陷猪是一种新型的代谢性肝病大型动物模型。
Stem Cell Res. 2014 Jul;13(1):144-53. doi: 10.1016/j.scr.2014.05.003. Epub 2014 May 14.
4
Identification of Novel Mutations in FAH Gene and Prenatal Diagnosis of Tyrosinemia in Indian Family.印度家族中FAH基因新突变的鉴定及酪氨酸血症的产前诊断
Case Rep Genet. 2012;2012:428075. doi: 10.1155/2012/428075. Epub 2012 Oct 30.
5
Tyrosinemia type I--diagnostic issues and prenatal diagnosis.
Indian J Pediatr. 2006 Feb;73(2):163-5. doi: 10.1007/BF02820214.
6
Current strategies for the treatment of hereditary tyrosinemia type I.目前治疗I型遗传性酪氨酸血症的策略。
Paediatr Drugs. 2006;8(1):47-54. doi: 10.2165/00148581-200608010-00004.
7
Hereditary tyrosinemia type I: strong association with haplotype 6 in French Canadians permits simple carrier detection and prenatal diagnosis.I型遗传性酪氨酸血症:在法裔加拿大人中与单倍型6密切相关,便于进行简单的携带者检测和产前诊断。
Am J Hum Genet. 1994 Aug;55(2):327-33.
8
Prenatal diagnosis of tyrosinaemia type I by use of stable isotope dilution mass spectrometry.利用稳定同位素稀释质谱法进行Ⅰ型酪氨酸血症的产前诊断。
Eur J Pediatr. 1985 Jul;144(2):209-10. doi: 10.1007/BF00451920.
9
Prenatal diagnosis of hereditary tyrosinaemia type I by determination of fumarylacetoacetase in chorionic villus material.
Eur J Pediatr. 1986 Apr;144(6):597-8. doi: 10.1007/BF00496047.
10
Prenatal diagnosis of inborn errors of metabolism with renal manifestations.伴有肾脏表现的先天性代谢缺陷的产前诊断。
Pediatr Nephrol. 1987 Jul;1(3):540-5. doi: 10.1007/BF00849267.